Blood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 ...

CLL/SLL是一种成熟B淋巴细胞克隆增殖性肿瘤，以淋巴细胞在外周血、骨髓、脾脏和淋巴结聚集为特征，也是西方成人中最常见的白血病类型2。欧美人群中年发病率达到（4-5）/10万，亚洲人群的发病率则是欧美的1/10。欧美中位发病年龄在70-75岁，而中 ...

这篇综述聚焦慢性淋巴细胞白血病（CLL）/ 小淋巴细胞淋巴瘤（SLL）治疗。经系统分析发现，维奈克拉（Venetoclax）为基础的疗法可显著延长患者无进展生存期（PFS）、总生存期（OS）和下次治疗时间（TTNT），且安全性与传统化疗相当，值得关注。 ### 慢性淋巴 ...

In just over a year since its US Food and Drug Administration (FDA) approval, pirtobrutinib (Jayprica) has become a standard ...

为探究慢性淋巴细胞白血病（CLL）中枢神经系统（CNS）受累时双侧视神经病变情况，研究人员报告 1 例新病例，发现脑脊液免疫分型可行，激素治疗有效，为诊疗提供参考。 在血液疾病的领域中，慢性淋巴细胞白血病（Chronic Lymphocytic Leukemia，CLL）是成年人群里最为常见的白血病类型。在美国，每年有超过 20 万人受其困扰，约 4410 人因此失去生命。CLL ...

Evidence shows pausing BTKi therapy for COVID-19 vaccination does not affect antibody responses to the vaccine ...

Blood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 vaccinations, a new study ...

A study of 200 patients with chronic lymphocytic leukemia (CLL) showed a lower rate of severe and serious adverse events ...

During a Case-Based Roundtable® event, John N. Allan, MD, discussed how new regimens using BTK inhibitors and venetoclax ...

Managing diabetes and chronic lymphocytic leukemia is challenging, but with proactive care, mindfulness and diet changes, I'm ...

Blood tests, bone marrow tests, imaging tests, and biopsy are some of the tests used to help diagnose chronic lymphocytic leukemia (CLL). Chronic lymphocytic leukemia (CLL) is a slow-growing ...

Minimal residual disease negativity was achieved at a significantly higher rate with venetoclax-based therapies, supporting its role in CLL.